The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Janssen Pharms' Xarelto is prescribed to reduce the risk ... for months after the CMS selected 10 high-priced, single-source drugs that didn't have generic or competitor versions to renegotiate ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

The same is true with other popular medicines such as psoriasis treatment Otezla, blood thinner Xarelto and generic versions of the cancer drug Tykerb, known as lapatinib, which has 460 prices ...

While Xarelto sales fell 15% from 4.1 billion euros ... The gain comes as Bayer’s partner Regeneron—which commercializes the drug in the U.S.—has seen a slight decline in sales over the ...

Those drugs were Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp/NovoLog. CMS is following a certain set of parameters to determine which drugs are ...

Late last week, J&J said that the new approach for Xarelto and Stelara – both drugs subject to the first round of Medicare negotiations under the Inflation Reduction Act (IRA) with prices ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

J&J – which jointly developed Xarelto with Bayer – has US commercial rights to the drug and sells it as 2.5mg, as well as 10mg, 15mg, and 25mg tablets, along with a 1mg/ml oral suspension ...